Docetaxel and atrasentan versus docetaxel and placebo for men with advanced castration-resistant prostate cancer (SWOG S0421): a randomised phase 3 trial

✍ Scribed by Quinn, David I; Tangen, Catherine M; Hussain, Maha; Lara, Primo N; Goldkorn, Amir; Moinpour, Carol M; Garzotto, Mark G; Mack, Philip C; Carducci, Michael A; Monk, J Paul; Twardowski, Przemyslaw W; Van Veldhuizen, Peter J; Agarwal, Neeraj; Higano, Celestia S; Vogelzang, Nicholas J; Thompson, Ian M

• Book ID: 122946198
• Publisher: The Lancet
• Year: 2013
• Tongue: English
• Weight: 261 KB
• Volume: 14
• Category: Article
• ISSN: 1470-2045
• DOI: 10.1016/S1470-2045(13)70294-8